Sutro Biopharma, Inc. (STRO) financial statements and ratios from SEC XBRL: revenue $102.48M (TTM), net margin -186.5%, revenue growth 65.2% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $102.48M |
| Net Margin | -186.5% |
| Revenue Growth (YoY) | 65.2% |
| EPS Growth (YoY) | 659.8% |
| Price / Sales | 7.15 |
| Altman Z-Score | -9.09 (distress) |
| Sector P/E (Healthcare) | 21.7 |
STRO overview · STRO earnings · STRO KPIs · STRO investor relations · STRO ownership · STRO peers · STRO filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.